Valve Burden–Related Cardiac Remodeling in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
Valve Burden–Related Cardiac Remodeling in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Rina
Takahashi
Rina Takahashi 9rina22@gmail.com Tokyo Women's Medical University Department of Nephrology Tokyo Japan *
Yuki Kobayashi 11230038ky@twmu.ac.jp Tokyo Women's Medical University Department of Nephrology Tokyo Japan -
Hiroshi Kataoka kataoka.hiroshi@twmu.ac.jp Tokyo Women's Medical University Department of Nephrology Tokyo Japan -
Yusuke Ushio ushio.yusuke@twmu.ac.jp Tokyo Women's Medical University Department of Nephrology Tokyo Japan -
Shiho Makabe makabe.shiho@twmu.ac.jp Tokyo Women's Medical University Department of Nephrology Tokyo Japan -
Shun Manabe manabe.shun@twmu.ac.jp Tokyo Women's Medical University Department of Nephrology Tokyo Japan -
Junichi Hoshino hoshino.junichi@twmu.ac.jp Tokyo Women's Medical University Department of Nephrology Tokyo Japan -
 
 
 
 
 
 
 
 

Valvular regurgitation is a frequent but underrecognized feature of ADPKD. Although traditionally viewed as a benign finding, emerging evidence indicates that even mild valvular lesions can contribute to chronic volume load, potentially leading to early cardiac remodeling before overt dysfunction. Given the systemic connective tissue abnormalities inherent in ADPKD, valvular degeneration could represent part of the disease spectrum. However, whether such valvular abnormalities translate into measurable subclinical remodeling has not been well clarified. We aimed to determine whether the cumulative number of regurgitant valves correlates with echocardiographic indices of remodeling and whether global systolic and right ventricular functions remain preserved.

We retrospectively analyzed 99 patients with ADPKD who underwent comprehensive transthoracic echocardiography at a tertiary nephrology center. Valvular involvement (≥mild) of the mitral, aortic, tricuspid, or pulmonary valve was counted (range 0–4) to define the number of regurgitant valves (Num). Echocardiographic parameters included left ventricular mass index (LVMI), left atrial volume index (LAVI), E/e′ ratio (LV filling pressure), right atrial enlargement (RA_enlarged), left ventricular ejection fraction (LVEF), tricuspid annular plane systolic excursion (TAPSE), and right ventricular systolic pressure (RVSP). Multivariable linear and logistic regression models were adjusted for age and sex. Analyses involving Num were performed among evaluable patients with complete valve grading.

In univariate analysis, patients with any valvular regurgitation had significantly higher LVMI than those without (80.9 ± 23.5 vs. 55.6 ± 5.9 g/m²; p = 0.020), supporting the association between valvular involvement and structural remodeling. Among evaluable patients with complete valve grading (n = 24), 79% had ≥1 regurgitant valve and 50% had ≥2, indicating that multivalvular involvement is not uncommon in ADPKD. Each additional regurgitant valve was associated with a significant increase in LVMI (+8.24 g/m² per valve; 95% CI 1.74–14.74; p = 0.016), independent of age and sex (Figure). Right atrial enlargement was associated with tricuspid regurgitation (OR 4.46; 95% CI 1.10–18.0; p = 0.036), and mitral regurgitation tended to correlate with elevated E/e′ ≥14 (OR 3.03; p = 0.095). Aortic regurgitation showed a nonsignificant trend toward higher LVMI (+12.2; p = 0.13). Despite these structural alterations, cardiac systolic and right ventricular functions remained preserved: LVEF (β = +0.59, p = 0.39), TAPSE (β = +2.29, p = 0.27), and RVSP (β = −0.17, p = 0.76). This pattern indicates that structural rather than functional remodeling predominates in early ADPKD, consistent with a burden-dependent continuum of cardiac involvement.

Valvular regurgitation, often regarded as a benign comorbidity, may in fact represent an early cardiac manifestation of systemic connective tissue involvement in ADPKD. Our findings demonstrate that the cumulative valvular burden correlates with left ventricular hypertrophy, marking the onset of structural remodeling even before measurable systolic dysfunction. Valve-specific associations (TR → RA enlargement; MR → diastolic load) support chamber-consistent remodeling pathways, suggesting that valvular lesions are not incidental but pathophysiologically relevant. Recognizing these subtle changes may help identify patients at risk of progressive cardiac remodeling. Accordingly, routine echocardiographic surveillance focusing on valvular burden and early chamber remodeling may contribute to proactive risk stratification and timely cardioprotective management in ADPKD, even in patients without overt heart failure or reduced ejection fraction.

Kewords